Finista-M Tablet is a combination medication containing Montelukast 10mg and Fexofenadine 120mg, designed to provide effective relief from allergic conditions such as seasonal allergic rhinitis and chronic urticaria. Montelukast, a leukotriene receptor antagonist, works by blocking substances in the body called leukotrienes that cause allergy symptoms like inflammation, swelling, and bronchoconstriction. Fexofenadine, a second-generation antihistamine, selectively inhibits peripheral H1 receptors, reducing symptoms such as sneezing, runny nose, itching, and watery eyes without causing significant drowsiness. Together, these active ingredients offer a comprehensive approach to managing allergy symptoms by targeting multiple pathways involved in the allergic response. Finista-M is typically prescribed for adults and children above 12 years of age and should be taken orally as directed by a healthcare professional. It is important to follow the prescribed dosage and avoid self-medication. Common side effects may include headache, dizziness, or gastrointestinal discomfort, but the combination is generally well-tolerated. Patients with liver impairment or known hypersensitivity to either component should use this medication cautiously. Always consult a healthcare provider before starting Finista-M Tablet to ensure it is appropriate for your condition and to avoid potential drug interactions.